Tag Archives: SBUX

Best High Tech Stocks For 2019

Leave a reply

LISTEN TO ARTICLE 2:16 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Bahrain and its Gulf Arab allies are said to be making progress on an aid program to help the island-kingdom repair its finances and avoid a devaluation that could roil neighboring markets.

Officials from Bahrain, Saudi Arabia, the United Arab Emirates and Kuwait are discussing a multi-year program that would involve spending cuts and measures to increase non-oil revenue, including the introduction of a value-added tax, according to five people with knowledge of the matter. They asked not to be identified because the details aren’t public.

Best High Tech Stocks For 2019: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Starbucks Corp. (NYSE: SBUX) fell about 1.1% Tuesday to post a new 52-week low of $50.11. Shares closed at $50.66 on Monday. The 52-week high is $61.94. Volume of around 10 million was about 3% higher than the daily average. The company had no specific news but a rival chain is stepping in to open new stores.

  • [By Billy Duberstein]

    After stagnating over the course of two and half years, Starbucks (NASDAQ:SBUX) stock is showing signs of perking up. In fact, since its summer swoon, better-than-expected earnings have catapulted shares a handsome 40% off their July 2018 lows.

  • [By Douglas A. McIntyre]

    Starbucks Corp. (NASDAQ: SBUX) has a new benefit for employees: child and adult care support. With a company called Care.com, it will start a new program. And the prices to Starbucks employees will be very low.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Starbucks (SBUX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel B. Kline]

    Visit nearly any Starbucks (NASDAQ:SBUX) at almost any time of day, and you’ll see proof that the company has succeeded in its goal of becoming a “third place” — a social center beyond the home or the workplace. Its tables may be occupied by people working on novels, groups of friends chatting, businesspeople conducting meetings, and maybe even couples on dates.

  • [By Max Byerly]

    Gabelli Funds LLC raised its holdings in Starbucks (NASDAQ:SBUX) by 33.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 433,317 shares of the coffee company’s stock after acquiring an additional 109,000 shares during the quarter. Gabelli Funds LLC’s holdings in Starbucks were worth $25,085,000 as of its most recent filing with the Securities and Exchange Commission.

Best High Tech Stocks For 2019: Aerohive Networks, Inc.(HIVE)

Advisors’ Opinion:

  • [By Max Byerly]

    Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

  • [By Stephan Byrd]

    Here are some of the news articles that may have effected Accern’s rankings:

    Get Anthera Pharmaceuticals alerts:

    Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)

    ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.

  • [By Logan Wallace]

    Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.

  • [By ]

    Our Biggest Loser… And A Bunch Of Big Wins
    Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade.

Best High Tech Stocks For 2019: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Aperio Group LLC increased its position in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) by 49.5% in the first quarter, HoldingsChannel reports. The institutional investor owned 19,270 shares of the biopharmaceutical company’s stock after buying an additional 6,377 shares during the period. Aperio Group LLC’s holdings in Lexicon Pharmaceuticals were worth $165,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    Sanofi’s also awaiting an FDA decision on sotagliflozin, a drug it licensed from Lexicon Pharmaceuticals (NASDAQ:LXRX) in 2015 for $300 million up front, up to $430 million in development and regulatory milestones, up to $990 million in specified sales milestones, and tiered, escalating royalties ranging from low double-digit percentages to 40% of net sales. 

  • [By Chris Lange]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) is making presentations at the American Diabetes Association on June 22 to 26. Lexicon recently traded at $13.58 a share, with a consensus analyst price target of $23.00 and a 52-week trading range of $7.67 to $18.00.

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.

Best High Tech Stocks For 2019: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on NeoGenomics (NEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    NEO (CURRENCY:NEO) traded up 3.5% against the dollar during the 1-day period ending at 16:00 PM Eastern on October 8th. NEO has a market capitalization of $1.21 billion and $161.27 million worth of NEO was traded on exchanges in the last day. One NEO coin can currently be purchased for approximately $18.64 or 0.00280368 BTC on major cryptocurrency exchanges including LBank, ZB.COM, Gate.io and Allcoin. In the last seven days, NEO has traded up 0.6% against the dollar.

  • [By Joseph Griffin]

    These are some of the media stories that may have effected Accern’s analysis:

    Get NeoGenomics alerts:

    NeoGenomics (NEO) Receives Buy Rating from Stephens (americanbankingnews.com) NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock (finance.yahoo.com) Q2 2018 EPS Estimates for NeoGenomics, Inc. Cut by William Blair (NEO) (americanbankingnews.com) NeoGenomics (NEO) Receives Buy Rating from BTIG Research (americanbankingnews.com) Steven C. Jones Sells 2,000 Shares of NeoGenomics, Inc. (NEO) Stock (americanbankingnews.com)

    NeoGenomics traded up $0.40, hitting $13.90, during trading on Tuesday, MarketBeat Ratings reports. 6,150 shares of the company’s stock traded hands, compared to its average volume of 498,468. NeoGenomics has a 52 week low of $7.08 and a 52 week high of $14.18. The company has a quick ratio of 1.85, a current ratio of 2.03 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $1.13 billion, a P/E ratio of 231.50, a price-to-earnings-growth ratio of 6.69 and a beta of 0.48.

  • [By Ethan Ryder]

    BidaskClub lowered shares of NeoGenomics (NASDAQ:NEO) from a strong-buy rating to a buy rating in a research note published on Wednesday.

    Several other equities research analysts have also weighed in on the company. Leerink Swann began coverage on NeoGenomics in a report on Tuesday, August 21st. They issued an outperform rating and a $18.00 price objective for the company. Zacks Investment Research lowered NeoGenomics from a hold rating to a sell rating in a report on Thursday, July 19th. First Analysis set a $16.00 target price on NeoGenomics and gave the company a buy rating in a report on Tuesday, September 18th. BTIG Research reaffirmed a buy rating and set a $15.00 target price on shares of NeoGenomics in a report on Thursday, June 21st. Finally, Stephens reaffirmed a buy rating and set a $15.00 target price on shares of NeoGenomics in a report on Tuesday, June 26th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of $19.25.

Best High Tech Stocks For 2019: Tesla Motors, Inc.(TSLA)

Advisors’ Opinion:

  • [By John Rosevear]

    This is an important deal. Tesla’s (NASDAQ:TSLA) Supercharger network has given it a big advantage in winning buyers away from internal-combustion alternatives. Any company looking to challenge Tesla will be at a disadvantage unless it can also provide its buyers with assurance that they’ll be able to access high-speed chargers on road trips. 

  • [By ]

    The solution to this problem — that is, night — is to build huge batteries, something that so far has been a real challenge. Right now, Tesla (Nasdaq: TSLA) has the world’s largest battery, a 100-megawatt beauty in Australia, about the size of a U.S. football field. That makes for a lot o’ juice. Enough, in fact, to power 30,000 homes.

  • [By John Rosevear]

    General Motors (NYSE:GM) and Honda Motor (NYSE:HMC) announced that they plan to team up on advanced batteries for electric vehicles in a bid to push back against Tesla (NASDAQ:TSLA) and its massive Gigafactory.

  • [By Rich Smith]

    I dusted off my crystal ball earlier this year and made three (I thought not very) bold predictions about what investors could expect from Tesla (NASDAQ:TSLA) stock in 2018. As we approach the midpoint mark of the year, however, it looks like I’m batting only .333:

Best High Tech Stocks For 2019: OraSure Technologies, Inc.(OSUR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Integra Lifesciences (NASDAQ: OSUR) and OraSure Technologies (NASDAQ:OSUR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OraSure Technologies (OSUR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) have been given an average rating of “Buy” by the seven research firms that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $20.00.

  • [By Max Byerly]

    SurModics (NASDAQ: OSUR) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, earnings, profitability and analyst recommendations.

Hot Value Stocks To Invest In Right Now

Leave a reply

SG Americas Securities LLC raised its stake in shares of Milacron Holdings Corp (NYSE:MCRN) by 34.7% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 12,820 shares of the industrial products company’s stock after buying an additional 3,304 shares during the period. SG Americas Securities LLC’s holdings in Milacron were worth $258,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB purchased a new position in shares of Milacron during the 4th quarter valued at about $193,000. OppenheimerFunds Inc. purchased a new position in shares of Milacron during the 4th quarter valued at about $201,000. US Bancorp DE raised its stake in shares of Milacron by 95.8% during the 4th quarter. US Bancorp DE now owns 12,948 shares of the industrial products company’s stock valued at $248,000 after buying an additional 6,335 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Milacron during the 4th quarter valued at about $284,000. Finally, Teacher Retirement System of Texas purchased a new position in shares of Milacron during the 4th quarter valued at about $454,000. Institutional investors and hedge funds own 99.38% of the company’s stock.

Hot Value Stocks To Invest In Right Now: Plains Group Holdings, L.P.(PAGP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TheStreet upgraded shares of Plains GP (NYSE:PAGP) from a d+ rating to a c- rating in a research report released on Monday morning.

    Several other analysts have also recently issued reports on the company. Stifel Nicolaus cut Plains GP from a buy rating to a hold rating and set a $24.00 price objective on the stock. in a report on Wednesday. Jefferies Group cut Plains GP from a buy rating to a hold rating in a report on Wednesday, April 25th. Wolfe Research cut Plains GP from a market perform rating to an underperform rating in a report on Tuesday, April 24th. Deutsche Bank began coverage on Plains GP in a report on Thursday, April 19th. They set a buy rating and a $29.00 price objective on the stock. Finally, SunTrust Banks raised Plains GP from a hold rating to a buy rating and set a $27.00 price objective on the stock in a report on Monday, April 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of Hold and a consensus price target of $25.65.

  • [By Shane Hupp]

    News coverage about Plains GP (NYSE:PAGP) has been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Plains GP earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the pipeline company an impact score of 46.0549967457103 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s rankings:

    Get Plains GP alerts:

    Plains GP (PAGP) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS (americanbankingnews.com) Plains GP (PAGP) Upgraded by TheStreet to C- (americanbankingnews.com) Plains GP (PAGP) Downgraded by Stifel Nicolaus (americanbankingnews.com) Plains GP Holdings (PAGP) Tops Q1 EPS by 5c, Beats on Revenues (streetinsider.com) Plains All American Pipeline, L.P. and Plains GP Holdings Report First-Quarter 2018 Results (finance.yahoo.com)

    Several research firms have commented on PAGP. TheStreet upgraded shares of Plains GP from a “d+” rating to a “c-” rating in a research report on Monday. Stifel Nicolaus cut shares of Plains GP from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research report on Wednesday. Jefferies Group cut shares of Plains GP from a “buy” rating to a “hold” rating in a research report on Wednesday, April 25th. Wolfe Research cut shares of Plains GP from a “market perform” rating to an “underperform” rating in a research report on Tuesday, April 24th. Finally, Deutsche Bank began coverage on shares of Plains GP in a research report on Thursday, April 19th. They issued a “buy” rating and a $29.00 target price for the company. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $25.65.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Plains GP (PAGP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Two years ago, Plains All American Pipeline (NYSE:PAA) and Plains GP Holdings (NYSE:PAGP) took a step to simplify their corporate structure by eliminating the costly incentive distribution rights (IDRs) that Plains All American paid to Plains GP. In exchange, Plains GP acquired a 34.8% stake in the MLP. While that deal was certainly a step in the right direction, the companies could eventually take the next logical progression by combining into one entity.

  • [By Joseph Griffin]

    Plains GP (NYSE:PAGP) was downgraded by equities researchers at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a note issued to investors on Monday, The Fly reports.

Hot Value Stocks To Invest In Right Now: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Rich Duprey]

    Starbucks (NASDAQ:SBUX) may consider itself a “third place” (after the home and the workplace) for people, but it should place first in the minds of those looking for a quality investment.

  • [By Chris Lange]

    Starbucks Corp. (NASDAQ: SBUX) saw its shares dip on Wednesday after the company announced that it would be undertaking new initiatives to help grow the company in the United States and China. Part of these initiatives would be accelerating its store closures as a result of sluggish sales.

  • [By ] When it comes to mobile payments, most people likely think ofApple(NASDAQ: AAPL) Pay or Alphabet’s (NASDAQ: GOOG)(NASDAQ: GOOGL) Google Pay. However, a recent eMarketer studyfound that Starbucks(NASDAQ: SBUX) actually has the top proximity mobile payment app in the United States.

  • [By Logan Wallace]

    Starbucks (NASDAQ: SBUX) and GREENE KING PLC/S (OTCMKTS:GKNGY) are both retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Hot Value Stocks To Invest In Right Now: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Max Byerly]

    Genomic Health (NASDAQ:GHDX) – Stock analysts at William Blair issued their Q1 2019 earnings estimates for Genomic Health in a research note issued to investors on Monday, June 4th. William Blair analyst A. Murphy forecasts that the medical research company will post earnings of $0.12 per share for the quarter. William Blair also issued estimates for Genomic Health’s Q2 2019 earnings at $0.16 EPS, Q3 2019 earnings at $0.20 EPS and Q4 2019 earnings at $0.21 EPS.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get Genomic Health alerts:

    Zacks: Brokerages Expect Genomic Health, Inc. (GHDX) to Post $0.07 EPS (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Catches Eye: Stock Jumps 8.5% (finance.yahoo.com) Genomic Health (GHDX) vs. Veracyte (VCYT) Head-To-Head Contrast (americanbankingnews.com) PetMed (PETS) Optimistic About New Orders Amid Cost Woes (finance.yahoo.com) Genomic Health Inc. (GHDX) PT Raised to $56 at Canaccord Genuity (streetinsider.com)

    Genomic Health stock traded up $0.57 during mid-day trading on Wednesday, hitting $50.58. 868 shares of the company’s stock were exchanged, compared to its average volume of 337,252. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of 5,058.00 and a beta of 0.64. Genomic Health has a 1-year low of $26.54 and a 1-year high of $53.65.

  • [By Stephan Byrd]

    Genomic Health, Inc. (NASDAQ:GHDX) insider Kimberly J. Popovits sold 10,000 shares of Genomic Health stock in a transaction on Thursday, June 14th. The shares were sold at an average price of $48.89, for a total value of $488,900.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

Top 5 Heal Care Stocks To Buy For 2019

Leave a reply

Advantus Capital Management Inc lowered its holdings in LTC Properties, Inc. (NYSE:LTC) by 25.6% in the first quarter, HoldingsChannel.com reports. The firm owned 18,604 shares of the real estate investment trust’s stock after selling 6,400 shares during the quarter. Advantus Capital Management Inc’s holdings in LTC Properties were worth $707,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Rhumbline Advisers lifted its holdings in shares of LTC Properties by 11.2% during the 1st quarter. Rhumbline Advisers now owns 130,124 shares of the real estate investment trust’s stock worth $4,945,000 after acquiring an additional 13,153 shares during the period. Wells Fargo & Company MN lifted its holdings in shares of LTC Properties by 21.5% during the 1st quarter. Wells Fargo & Company MN now owns 171,196 shares of the real estate investment trust’s stock worth $6,505,000 after acquiring an additional 30,272 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new stake in shares of LTC Properties during the 4th quarter worth approximately $322,000. MetLife Investment Advisors LLC bought a new stake in shares of LTC Properties during the 4th quarter worth approximately $779,000. Finally, Macquarie Group Ltd. lifted its holdings in shares of LTC Properties by 18.3% during the 4th quarter. Macquarie Group Ltd. now owns 16,125 shares of the real estate investment trust’s stock worth $200,000 after acquiring an additional 2,500 shares during the period. 80.28% of the stock is owned by hedge funds and other institutional investors.

Top 5 Heal Care Stocks To Buy For 2019: HSBC Holdings plc(HSEA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares rose 29.5 percent to $2.15 in pre-market trading after reporting pre-clinical data demonstrating potential of Prexigebersen presented at the annual American Association for Cancer Research meeting in Chicago.
    Sientra, Inc. (NASDAQ: SIEN) rose 16.7 percent to $12.90 in pre-market trading following the announcement of FDA approval for PMA supplement.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 13.5 percent to $2.95 in pre-market trading after climbing 14.04 percent on Wednesday.
    Harmony Gold Mining Company Limited (NYSE: HMY) rose 5.6 percent to $2.09 in pre-market trading.
    Alcoa Corporation (NYSE: AA) shares rose 5 percent to $62.32 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its FY18 adjusted EBITDA outlook.
    Gold Fields Limited (ADR) (NYSE: GFI) shares rose 4.9 percent to $4.11 in pre-market trading after gaining 1.03 percent on Wednesday.
    ABB Ltd (NYSE: ABB) shares rose 4.3 percent to $24.47 in pre-market trading after reporting Q1 results.
    WPP plc (NYSE: WPP) rose 4.2 percent to $82.99 in pre-market trading.
    American Express Company (NYSE: AXP) rose 4 percent to $98.95 in pre-market trading after the company reported stronger-than-expected profit for its first quarter.
    HSBC Holdings plc (NYSE: HSEA) rose 3.4 percent to $27.30 in pre-market trading.
    Shire plc (NASDAQ: SHPG) rose 3.4 percent to $167.95 in pre-market trading. Takada offered to buy Shire at £46.50 per share, Reuters reported.
    Vipshop Holdings Limited (NYSE: VIPS) rose 3.1 percent to $16.43 in pre-market trading.
    iRobot Corporation (NASDAQ: IRBT) shares rose 3 percent to $63.66 in the pre-market trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday.
    Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday.
    Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings.
    Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results.
    Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings.
    HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results.
    Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday.
    Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading.
    Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results.
    HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr

Top 5 Heal Care Stocks To Buy For 2019: Natural Gas Services Group, Inc.(NGS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Natural Gas Services Group, Inc. Common Stock (NYSE:NGS) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Thursday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Natural Gas Services Group, Inc. Common Stock (NGS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Buy For 2019: Nuveen Tax-Advantaged Total Return Strategy Fund(JTA)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN decreased its holdings in Nuveen Tax Advantaged Total Re (NYSE:JTA) by 48.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,813 shares of the investment management company’s stock after selling 10,055 shares during the period. Wells Fargo & Company MN owned approximately 0.08% of Nuveen Tax Advantaged Total Re worth $150,000 as of its most recent SEC filing.

Top 5 Heal Care Stocks To Buy For 2019: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Jason Hall, Neha Chamaria, and Rich Duprey]

    Three that look particularly appealing today includeBest Buy Co Inc(NYSE:BBY),Nucor Corporation(NYSE:NUE), andStarbucks Corporation(NASDAQ:SBUX). Not only do all three pay dividends yielding over 2%, but they also have solid long-term prospects that should lead to growing your capital investment in them in the years ahead.

  • [By ]

    As Starbucks Corp.’s (SBUX)   former CEO Howard Schultz hit the airwaves on Wednesday to apologize and the company schedules a half-day for employee training addressing racial sensitivity, its reputation with the public has tumbled to the lowest point in more than two years, according to YouGov Brand Index, a daily brand consumer-perception company.

  • [By Paul Ausick]

    Starbucks Corp. (NYSE: SBUX) fell about 5% Thursday to post a new 52-week low of $47.37. Shares closed at $49.84 on Wednesday. The 52-week high is $61.94. Volume of around 28 million was about three times the daily average. The company’s 50-year old CFO announced his retirement this morning.

  • [By Leo Sun]

    When it comes to mobile payments, most people likely think ofApple (NASDAQ:AAPL) Pay or Alphabet’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google Pay. However, a recent eMarketer studyfound that Starbucks (NASDAQ:SBUX) actually has the top proximity mobile payment app in the United States.

Top 5 Heal Care Stocks To Buy For 2019: ADDvantage Technologies Group, Inc.(AEY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about ADDvantage Technologies Group (NASDAQ:AEY) has trended positive on Saturday, Accern Sentiment Analysis reports. The research firm scores the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. ADDvantage Technologies Group earned a media sentiment score of 0.47 on Accern’s scale. Accern also assigned media coverage about the technology company an impact score of 47.0561890892472 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Value Stocks To Invest In Right Now

Leave a reply

Loading the player…
What is ‘Internal Rate Of Return – IRR’

Internal rate of return (IRR) is a metric used in capital budgeting measuring the profitability of potential investments. Internal rate of return is a discount rate that makes the net present value (NPV) of all cash flows from a particular project equal to zero. IRR calculations rely on the same formula as NPV does.

The following is the formula for calculating NPV:

where:

Ct= net cash inflow during the period t

Co= total initial investment costs

r = discount rate, and

t = number of time periods

To calculate IRR using the formula, one would set NPV equal to zero and solve for the discount rate r, which is here the IRR. Because of the nature of the formula, however, IRR cannot be calculated analytically, and must instead be calculated either through trial-and-error or using software programmed to calculate IRR.

Top 10 Value Stocks To Invest In Right Now: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    Quarterly results showStarbucks Corp. (NASDAQ: SBUX) has problems. According to Bloomberg:

    After another quarter of tepid sales growth, Starbucks Corp. Chief Financial Officer Scott Maw assured investors that the company is investing strategically and with a long game mentality. Wall Street may not be so patient.

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Paul Ausick]

    After markets close Thursday, Starbucks Corp. (NASDAQ: SBUX) is set to report fiscalsecond-quarter results. The early April incident in a Philadelphia store that resulted in the arrests (and later dropping of the charges) of two African-American men will receive special attention as it should but there are other issues that investors will also want to hear about.

Top 10 Value Stocks To Invest In Right Now: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: Celldex Therapeutics Inc(CLDX)

Advisors’ Opinion:

  • [By George Budwell]

    Shares of Celldex Therapeutics (NASDAQ:CLDX), a small-cap cancer company, are down by over 43% in pre-market trading today on extremely heavy volume. What’s going on?

  • [By Paul Ausick]

    Celldex Therapeutics Inc. (NASDAQ: CLDX) traded down nearly 65% Monday to post a new 52-week low of $0.76 after closing Friday at $2.15. The stock’s 52-week high is $3.42. Volume was about 25 times the daily average of around 1.4 million shares. The company’s breast cancer drug failed to meet a phase 2 study’s primary endpoint.

  • [By Todd Campbell]

    In this episode of The Motley Fool’s Industry Focus: Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to explain how Johnson & Johnson is doing and if it can overcome the threat to its top-selling drugs from generics. Plus, Harjes and Campbell weigh in on the Food and Drug Administration’s about-face on Alkermes’ (NASDAQ:ALKS) ALKS-5461 depression drug and what could be next for Celldex Therapeutics (NASDAQ:CLDX) following a disappointing flop for its lead drug candidate.

Top 10 Value Stocks To Invest In Right Now: Lincoln Educational Services Corporation(LINC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Lincoln Educational Services Co. (NASDAQ:LINC) – Equities research analysts at Barrington Research cut their Q3 2018 earnings per share estimates for shares of Lincoln Educational Services in a report released on Wednesday, May 9th. Barrington Research analyst A. Paris. Jr now anticipates that the company will post earnings per share of ($0.02) for the quarter, down from their prior estimate of ($0.01). Barrington Research has a “Buy” rating and a $2.50 price target on the stock. Barrington Research also issued estimates for Lincoln Educational Services’ FY2018 earnings at ($0.14) EPS.

Top 10 Value Stocks To Invest In Right Now: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By ]

    Already, shale companies such as Encana (ECA) , Occidental Petroleum (OXY) and Pioneer Natural Resources (PXD) , among others, are reporting higher cash flows and earnings on higher oil prices. As a result, they are paying down debt, increasing dividends and engaging in buybacks. This is a dramatic improvement in shareholder yield for the group.

  • [By Matthew DiLallo]

    Today, however, many drillers are setting a high bar for new wells. EOG Resources (NYSE:EOG) has been one of the leaders in disrupting the former way of thinking by establishing a high return hurdle rate for new wells of 30% after-tax at $40 oil. Others followed with similar return-focused approaches, including Encana (NYSE:ECA), which needs locations to achieve a 35% after-tax return at $50 oil to meet its premium hurdle rate.

Top 10 Value Stocks To Invest In Right Now: Greenhill & Co., Inc.(GHL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Greenhill & Co. (GHL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Greenhill & Co. (NYSE: GHL) is one of 31 publicly-traded companies in the “Security brokers & dealers” industry, but how does it compare to its competitors? We will compare Greenhill & Co. to related businesses based on the strength of its valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Top 10 Value Stocks To Invest In Right Now: Wolverine World Wide, Inc.(WWW)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    While that is happening in the Middle East, trouble is brewing in Washington. In addition to reports that a Russian Oligarch paid Trump’s lawyer $500,000, a U.S. telecom giant is now caught up with the same lawyer. AT&T Corporation (NYSE: T) confirmed Tuesday night that it paid Trump lawyer Michael Cohen for information on the administration. AT&T stock is up 0.6% in premarket hours.
    Four Stocks to Watch Today: TRIP, MTCH, FOXA, DIS
    Shares of TripAdvisor (Nasdaq: TRIP) popped nearly 20% after the company crushed earnings after the bell. In addition, the CFO Ernst Teunissen projected strong guidance for the rest of the year. The firm reported EPS of $0.30 on top of $378.0 million in revenue. Wall Street expected $0.16 per share on $360.84 million in revenue.
    Shares of Match Group (Nasdaq: MTCH) popped 3% after the company reported earnings after the bell. The dating site operator reported stronger than expected earnings and revenue figures on Tuesday. Overall, revenue jumped 36% compared to the same period in 2017. The firm also reported stronger than expected guidance. Of course, all anyone is talking about how Facebook Inc. (Nasdaq: FB) could impact the dating industry with its new plugin.
    Shares of 21st Century Fox (NYSE FOXA) are in focus as the firm prepares to report earnings before the bell. However, investors are more likely focused today on the expected bidding war between the Walt Disney Co. (NYSE: DIS) and Comcast Corporation (Nasdaq: CMCSA) to purchase key assets of the company. Fox is also tied up in a bidding war with Comcast to purchase British television provider Sky (OTC MKTS: SKYAY).
    Look for additional earnings reports from Booking Holdings (Nasdaq: BKNG), com International (Nasdaq: CTRP), Sina Corp. (Nasdaq: SINA), Albermarle Corp. (NYSE: ALB), Mylan Inc. (NYSE: MYL), SolarEdge Technologies (Nasdaq: SEDG), Wolverine World Wide (NYSE: WWW), IAC Interactive Corp. (NYSE: IAC), and Cavium Inc. (Nasdaq: CAVM).

    Eight Seconds

  • [By Ethan Ryder]

    Wolverine World Wide (NYSE:WWW)’s share price gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $33.18, but opened at $32.32. Wolverine World Wide shares last traded at $31.45, with a volume of 29527 shares changing hands.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report

Top 10 Value Stocks To Invest In Right Now: BankUnited, Inc.(BKU)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get BankUnited alerts:

    BankUnited (BKU) Expected to Post Quarterly Sales of $277.17 Million (americanbankingnews.com) BankUnited (BKU) Insider Sells $40,630.00 in Stock (americanbankingnews.com) BankUnited (BKU) Expected to Announce Earnings of $0.79 Per Share (americanbankingnews.com) Head to Head Contrast: BankUnited (BKU) and Capitol Federal Financial (CFFN) (americanbankingnews.com)

    NYSE BKU opened at $40.62 on Wednesday. BankUnited has a 12-month low of $30.37 and a 12-month high of $43.84. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.96 and a current ratio of 0.96. The company has a market capitalization of $4.30 billion, a PE ratio of 15.33, a price-to-earnings-growth ratio of 1.39 and a beta of 1.04.

  • [By Joseph Griffin]

    BankUnited (NYSE: BKU) and Capitol Federal Financial (NASDAQ:CFFN) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

  • [By Shane Hupp]

    BankUnited (NYSE:BKU) insider Mark Bagnoli sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 4th. The stock was sold at an average price of $40.63, for a total value of $40,630.00. Following the completion of the transaction, the insider now directly owns 25,118 shares in the company, valued at $1,020,544.34. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Top 10 Value Stocks To Invest In Right Now: CYS Investments, Inc.(CYS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Comstock Resources, Inc. (NYSE: CRK) shares shot up 52 percent to $7.235 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    MarineMax, Inc. (NYSE: HZO) shares gained 24.2 percent to $21.80 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Mattersight Corporation (NASDAQ: MATR) shares rose 22 percent to $2.625 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) jumped 21.3 percent to $411.871 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 17 percent to $3.10 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) rose 15.9 percent to $18.34 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) gained 15.6 percent to $12.20 following Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) surged 14.4 percent to $260.3901 following upbeat Q1 profit.
    Concord Medical Services Holdings Limited (NYSE: CCM) gained 13.8 percent to $3.70.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 13.5 percent to $29.815 after reporting strong Q1 results.
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 13.5 percent to $38.30 as the company reported stronger-than-expected earnings for its first quarter.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 13.1 percent to $10.985 as the company reported upbeat results for its first quarter.
    SJW Group (NYSE: SJW) shares gained 11.8 percent to $63.59 following Q1 results. California Water Service Group made an offer for SJW.
    Churchill Downs Incorporated (NASDAQ: CHDN) climbed 9.8 percent to $278.40 following Q1 results.
    CYS Investments, Inc. (NYSE: CYS)
  • [By Lisa Levin] Gainers
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 22.6 percent to $3.25 in pre-market trading after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Mattersight Corporation (NASDAQ: MATR) shares rose 23.2 percent to $2.65 in pre-market trading after the company agreed to be purchased by NICE Ltd.
    Comstock Resources, Inc. (NYSE: CRK) rose 21.2 percent to $5.77 in pre-market trading after the company disclosed a deal to buy oil & gas properties in North Dakota from Arkoma, Williston Drilling for about $620 million. The company also announced withdrawal of tender offers for outstanding secured notes.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 13.7 percent to $386.00 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Quantenna Communications, Inc. (NASDAQ: QTNA) shares rose 12.6 percent to $14.70 in pre-market trading. Quantenna is expected to release Q1 results on April 30..
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 11.1 percent to $37.50 in pre-market trading as the company reported stronger-than-expected earnings for its first quarter.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 10.4 percent to $29.00 in pre-market trading after reporting strong Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) rose 9.8 percent to $250.00 in pre-market trading following upbeat Q1 profit.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 9.4 percent to $10.62 in pre-market trading as the company reported upbeat results for its first quarter.
    CYS Investments, Inc. (NYSE: CYS) rose 9.1 percent to $7.22 in pre-market trading after the company agreed to be acquired by Two Harbors Investment Corp (NYSE: TWO).
    GNC Holdings, Inc. (NYSE: GNC) rose 8.3 percent to $4.18 in pre-market trading after reporting Q1 results.
    Domino's Pizza, Inc. (NYSE: DPZ) shares rose 7.6 percent to $251.2
  • [By Paul Ausick]

    CYS Investments Inc. (NYSE: CYS) traded down 5.6% Thursday and posted a new 52-week low of $6.25 after closing Wednesday at $6.62. The stock’s 52-week high is $8.98. Volume was around 4.6 million, about three times the daily average. The reported earnings last night. The shares have reversed their drop and are on track to close flat for the day or maybe even up a little.

  • [By Matthew Frankel]

    Mortgage real estate investment trust CYS Investments (NYSE:CYS) announced today that it had agreed to be acquired by fellow mortgage REIT Two Harbors Investment (NYSE:TWO).

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
    Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
    Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
    MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
    Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
    Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
    PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
    Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
    Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
    BioTelemetry,

Top 10 Value Stocks To Invest In Right Now: Aegion Corp(AEGN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Aegion (AEGN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Aegion (NASDAQ:AEGN) was upgraded by stock analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Nestle Will Help Starbucks Brew International Growth

Leave a reply

Starbucks (NASDAQ:SBUX) has an incredibly strong brand in the United States. It’s only a slight exaggeration to say there’s a Starbucks on every corner in some cities, and you have to have a strong brand to support over 17,000 stores in the Americas.

But Starbucks’ brand isn’t quite as strong in many of its international markets, and that’s where its recent deal with Nestle (NASDAQOTH:NSRGY) can help.

Nestle agreed to acquire the rights to market, sell, and distribute the Starbucks, Teavana, VIA, and other Starbucks brands. Nestle will also include the Starbucks brand in its single-serve Nespresso and Dolce Gusto at-home machines. (Starbucks’ ready-to-drink beverage partnerships will not be impacted.) In exchange, Starbucks will receive $7.15 billion and will remain the licensor and supplier for the products, providing it with ongoing revenue as well.

While Starbucks expects a small setback in revenue growth from the deal, its strategic benefits should produce a net positive for investors.

Person using the My Starbucks Rewards app

Image source: Starbucks.

Consumer packaged goods as a brand amplifier

During the conference call following the announcement of the deal, Starbucks CEO Kevin Johnson talked about the consumer packaged goods (CPG) business as a brand amplifier for Starbucks. The ability to buy roasted coffee or single-serve pods in stores allows consumers to connect with the Starbucks brand, sample new products, and engage with Starbucks more often. That strengthens the overall brand, and ultimately drives traffic to Starbucks stores.

But the CPG business is still nascent outside of the United States. Partnering with Nestle, which has global distribution in 191 markets (compared to 76 for Starbucks), will help it grow internationally.

Nestle also owns the largest installed base of at-home single-serve coffee machines, with Nespresso and Dolce Gusto. Starbucks has seen a lot of success with the Keurig K-Cup machines; expanding to Nestle’s machines will help build on that success without affecting its deal with Keurig.

Leveraging Nestle’s reach and scale to get Starbucks products into the homes of more international consumers will help build Starbucks’ brand globally. Ultimately, that should drive increased traffic to Starbucks stores, and allow Starbucks to rapidly expand to new markets.

Focusing on stores

Outsourcing marketing and distribution will help Starbucks focus more on its stores, which have recently struggled to keep pace with analyst expectations. To be sure, Starbucks still expects to work closely with Nestle to ensure that the CPG business is still benefiting its retail business, but it’s taking a lot off its plate.

Starbucks’ same-store sales grew just 2% year over year in its second quarter. That’s well behind the company’s outlook of 3% to 5% for 2018, which it now expects will come in at the low end. Still, investors seem wary that Starbucks will actually be able to exhibit that level of growth.

Shedding some of the operations of its CPG business could allow Starbucks to focus more of its resources on growing retail sales, opening new stores in new markets, and improving traffic, ticket size, and overall operations of its stores.

Boosting the buyback

Starbucks plans to take the $5 billion of after-tax income from Nestle and funnel it right into its capital return program. It now expects to return $20 billion to shareholders between 2018 and 2020, up from $15 billion.

Investors should see most of that $5 billion in the form of an increase in share repurchases in 2019. That’s key to CFO Scott Maw’s expectation that the deal will become accretive to earnings per share by the end of fiscal 2021, if not sooner.

In the near term, shedding the CPG business will negatively impact revenue growth by 2 to 3 percentage points. But the economics as a licensor and supplier to Nestle should help offset that in the long term, as Nestle’s distribution and marketing scale can increase total sales of Starbucks products in grocery stores. In the medium term, the buyback will help offset lost net income, by reducing shares outstanding and producing better earnings per share.

Overall, the deal is a positive development for Starbucks shareholders: It provides increased reach for the Starbucks brand internationally and allows the company to focus on its retail operations. The financial impact should benefit investors in the long term.